SCYL1 and neoplasm: The median OS for patients with NKTL as their first tumor was 26.0 months (95% CI 18.1‐33.9 mo), whereas it was only 11.0 months for patients with prior tumors (95% CI 6.1‐15.9 mo; P<.001).